Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

CUSIP: 185063104

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
76,991,404
Total 13F shares
7,836,345
Share change
-754,770
Total reported value
$6,816,461
Put/Call ratio
166%
Price per share
$0.87
Number of holders
45
Value change
-$748,299
Number of buys
14
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 185063104?
CUSIP 185063104 identifies CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q3 2023

As of 30 Sep 2023, Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,836,345 shares. The largest 10 holders included VANGUARD GROUP INC, Carmignac Gestion, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, FIRST MANHATTAN CO. LLC., JOHNSON & JOHNSON, and MORGAN STANLEY. This page lists 45 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.